Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out
March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Wednesday, April 22, 2020

EURORDIS initiative Survey COVID19 and Rare Diseases

where do we stand now in this pandemic as the unemployment rate has spiked?
The US National Organization Of Rare Diseases (NORD) has sent MEBO an invitation to "Make your voice heard!", a EURORDIS initiative. MEBO is an Organization Member of both these entities.

They invite us all from around the world (IN 23 LANGUAGES) to take a survey for a study which is looking at how we are affected by the COVID19 Pandemic. Their goal is to voice the specific needs of rare disease patients during this medical and economic crisis.

Please let us tell the world about the challenges we face due to this condition.

Even though sufferers have customarily had the tendency to live in relative reclusion and social distancing due to odor symptoms of TMAU, and our condition has made employment prospects challenging, where do we stand now in this pandemic as the unemployment rate has spiked?

What other impact has this had on people with uncontrollable odor conditions?

EURORDIS tells us:

Are you affected by a rare disease or a caring for someone affected by a rare disease? Share your experience and tell us how of the COVID-19 pandemic is affecting you by completing this survey.
The survey will only take around 15 minutes to answer.
This survey will help EURORDIS-Rare Diseases Europe, a non-profit and non-governmental alliance of 900+ patient organisations to understand your experience of the COVID-19 pandemic.
We will share the overall results of the survey with you and communicate them (without communicating your individual responses) to decision-makers. The goal is to voice the specific needs of rare disease patients’ in relation to the COVID-19 pandemic and to propose practical solutions to ensure rare diseases patients are take into account when handling the pandemic.
Your contact details and any written records of your responses during the study will be kept in secure storage which only the research team can access.

If you have any questions while taking part in this survey, you can contact, or call our office on +33 1 56 53 52 63.

MEBO Research has been a Member Organization for years of both, NORD and EURORDIS.


María de la Torre
Founder and Executive Director

A Public Charity
MEBO's Blog (English)
El Blog de MEBO (español)

SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online for the holidays
at no extra cost to you.
MEBO gets small commission from Amazon.

get New Posts by EMAIL : Enter your email address :

A EURORDIS and NORD Member Organization


Post a Comment